spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 2


Fig. 2. MT1-MMP promotes PDGFRβ- and PDGF-BB-dependent suppression of VSMC contractile proteins. (A) Quantitative assessment of SMA and calponin mRNA expression by real-time PCR. mRNA was isolated from subconfluent tenth-passage VSMCs cultured with the wide-spectrum MMP inhibitor BB-94 (10 µM), PDGFRβ kinase inhibitor AG1296 (10 µM) and EGFR tyrosine-kinase inhibitor AG1478 (10 µM) as indicated. The expression data are normalized against mouse TBP and presented relative to the mRNA expression in mock (0.1% DMSO)-treated wild-type cells (mean ±1 s.d., n=3). (B) Early-passage wild-type (MT1+/+) and MT1-MMP–/– VSMCs were cultured on polymerized collagen I in the presence of TIMP2 (4 µg/ml) for 48 hours as indicated, and exposed to PDGF-BB (25 ng/ml) under serum-free conditions. After 48 hours, the cells were lysed and the lysates analyzed by immunoblotting for the relative levels of calponin, SMA and vimentin. β-tubulin served as a loading control. Mean values of the ratios between normalized SMA and vimentin protein levels are presented below each lane (n=3). Relative mobilities of the molecular-mass markers are indicated in kDa. (C) Calponin expression was assessed by immunofluorescence staining of cells exposed to PDGF-BB as above. Filamentous actin was visualized with phalloidin (F-actin) and nuclei with DAPI. (D) MT1-MMP–/– VSMCs were transfected with EGFP expression-vector alone (Mock), or with either expression construct for wild-type MT1-MMP (MT1-MMP) or the catalytically inactive mutant (MT1-E240A) as indicated. Calponin expression (red) was assessed by immunofluorescence after 48 hours of treatment with PDGF-BB.





Right arrow Return to article